Ariel Precision Medicine was created to improve the lives of patients suffering with complex chronic diseases, starting with pancreatitis, a disease for which there is currently no treatment. Ariel is now applying new technology to accelerate the development of novel treatments to address the significant unmet need in pancreatitis.

Our advantage is both fueled and accelerated by ADVANCE®, a genetic segmentation platform, creating the ability to stratify patients into different disease sub-types and then model the appropriate mechanism of action to an effective therapy.